Supply Chain Orchestration, Priorities for Smaller CGT Biotechs

This segment of Cell & Gene Live, How CGT Developers Can Choose the Right Manufacturing Model for Their Pipeline, features Omkar Kawalekar, Ph.D., Manufacturing & Supply Chain Lead, Deloitte Consulting and Zoe Zheng, Executive Director, Pipeline Technical and Strategic Lead, Legend Biotech focuses on supply chain orchestration as a control-tower challenge, with the biggest vulnerabilities showing up in patient scheduling, data fragmentation, and QC/release bottlenecks. The panelists also offers practical guidance for smaller CGT biotechs to prioritize the risks that most affect patient safety, regulatory exposure, and reversibility, starting with end-to-end visibility and chain of identity/custody controls.